Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology

Acta Neuropathologica

Volumn 98, Issue 2, 1999, Pages 157-164

  Mattila, P M ^a   Rinne, J O ^a   Helenius, H ^b   Roytta M ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b NONE

Author keywords

Amygdala; Apolipoprotein E; Hippocampus; Neurites; Parkinson's disease

Indexed keywords

ANTIBODY; APOLIPOPROTEIN E4; TAU PROTEIN; UBIQUITIN;

ADULT; AGED; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATION; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; ENTORHINAL CORTEX; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEURITE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYGDALA; COGNITION DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE DEGENERATION; NEURITES; PARKINSON DISEASE;

EID: 0032818428     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010051064     Document Type: Article

References (28)

1. Braak H, Braak E (1987) Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 76: 124-127
2. Braak H, Braak E (1990) Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex. J Neural Transm [P-D Sect] 2: 45-57
3. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
4. Braak H, Braak E, Yilmazer D, Vos RAI de, Jansen ENH, Bohl J, Jellinger K (1994) Amygdala pathology in Parkinson's disease. Acta Neuropathol 88: 493-500
5. Dickson DW, Wertkin A, Kress Y, Ksiezak-Reding H, Yen S-H (1990) Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab Invest 63: 87-99
6. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen S-H (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 41: 1402-1409
7. Dickson DW, Schmidt ML, Lee VM-Y, Zhao M-L, Yen S-H, Trojanowski JQ (1994) Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease. Acta Neuropathol 87: 269-276
8. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55: 259-272
9. Gearing M, Schneider JA, Rebeck GW, Hyman BT, Mirra SS (1995) Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 45: 1985-1990
10. Herzog AG, Kemper TL (1980) Amygdaloid changes in aging and dementia. Arch Neurol 37: 625-629
11. Hyman BT, Hoesen GW van, Kramer LJ, Damasio AR (1986) Perforant pathway changes and the memory impairment of Alzheimer's disease. Ann Neurol 20: 472-481
12. Hyman BT, Kromer LJ, Hoesen GW van (1988) A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50. Brain Res 450: 392-397
13. Iseki E, Odawara T, Li F, Kosaka K, Nishimura T, Akiyama H, Ikeda K (1996) Age-related ubiquitin-positive granular structures in non-demented subjects and neurodegenerative disorders. J Neurol Sci 142: 25-29
14. Jellinger KA (1998) Dementia with grains (argyrophilic grain disease). Brain Pathol 8: 377-386
15. Jellinger K, Braak H, Braak E, Fischer P (1991) Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Ann NY Acad Sci 640: 203-209
16. Kim H, Gearing M, Mirra SS (1995) Ubiquitin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies. Neurology 45: 1768-1770
17. Kuljis RO, Martin-Vasallo P, Peress NS (1989) Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex. Neurosci Lett 106: 49-54
18. Lippa CF, Smith TW, Swearer JM (1994) Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 35: 81-88
19. Mattila PM, Röyttä M, Torikka H, Dickson DW, Rinne JO (1998) Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol 95: 576-582
20. Mattila PM, Koskela T, Röyttä M, Lehtimäki T, Pirttilä TA, Ilveskoski E, Karhunen P, Rinne JO (1998) Apolipoprotein E ε4 allele frequency is increased in Parkinson's disease only with coexisting Alzheimer pathology. Acta Neuropathol 96: 417-420
21. McKeith IG, Galasko D, Kosaka K, et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124
22. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L, participating CERAD neuropathologists (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486
23. Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52: 183-191
24. Reisberg B (1985) Alzheimer's disease update. Psychiatr Ann 15: 319-22
25. Rinne JO, Rummukainen J, Paljärvi L, Rinne UK (1989) Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26: 47-50
26. SAS/STAT User's Guide (1990) Version 6, 4th edn. SAS Institute, Cary
27. Tolnay M, Schwietert M, Monsch AU, Staehelin HB, Langui D, Probst A (1997) Argyrophilic grain disease: distribution of grains in patients with and without dementia. Acta Neuropathol 94: 353-358
28. Vos RAI de, Jansen ENH, Yilmazer D, Braak H, Braak E (1996) Pathological and clinical features of Parkinson's disease with and without dementia. In: Perry R, McKeith I, Perry E (eds) Dementia with Lewy bodies. Cambridge University Press, New York, pp 255-267